Tiotropium in asthma: what is the evidence and how does it fit in?
Open Access
- 1 January 2016
- journal article
- review article
- Published by Elsevier BV in World Allergy Organization Journal
- Vol. 9 (1), 29
- https://doi.org/10.1186/s40413-016-0119-y
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPDBritish Journal of Pharmacology, 2011
- Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI)Thorax, 2010
- Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled AsthmaThe New England Journal of Medicine, 2010
- Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPDPulmonary Pharmacology & Therapeutics, 2010
- Status of Asthma Control in Pediatric Primary Care: Results from the Pediatric Asthma Control Characteristics and Prevalence Survey Study (ACCESS)The Journal of Pediatrics, 2010
- Long-acting β2-adrenoceptor agonists: a smart choice for asthma?Trends in Pharmacological Sciences, 2007
- Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysisThorax, 2005
- Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung diseaseLife Sciences, 1999
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaThe New England Journal of Medicine, 1997
- Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.Thorax, 1992